CYPRESS, CA, March 13, 2010
/24-7PressRelease/ -- The new unit will enable WCCT to house additional clinical research participants, and expand their base of operations.
Dr. Tom Pillsworth, Vice President of Business Development has stated, "The new unit has been designed specifically for the continued strong interest by sponsors in conducting phase I studies in special populations. Specifically, given our recent conduct of multiple phase I pediatric trials (asthma, ADHD, GERD, allergic rhinitis, etc.) as a single site and continued interest in this study type, the Costa Mesa facility allows for these studies to be run apart from other adult population studies we currently have planned. It also is perfect for some of the special populations that are being requested by sponsors including: COPD, renally-impaired, Parkinson's Disease, cystic fibrosis, Alzheimer's Disease, etc.
WCCT has a unique focus on Ethno-bridging studies including Japanese bridging/population trials. In addition, WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Renal, Serial ECGs, and Vaccines.
About West Coast Clinical Trials, LLC
West Coast Clinical Trials (WCCT) is a private minority-owned independent Phase I-IV Clinical Research Organization located in Southern California. WCCT has 150 beds in two locations, over 40,000 square feet, and a well-trained and experienced staff bringing the highest quality to the pharmaceutical and biotechnology industries.
WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Immunology. WCCT has been conducting trials since 1998 and has been audited by the FDA and numerous pharmaceutical and biotechnology companies. Our location and access to an ethnically diverse population allows us to conduct a wide variety of studies designs including ethnic bridging, and specialty trials.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Trent Lapinski:Other Press Release Headlines:
